Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
19.7M
-
Shares change
-
+14.9M
-
Total reported value, excl. options
-
$148M
-
Value change
-
+$113M
-
Number of buys
-
48
-
Number of sells
-
-9
-
Price
-
$7.53
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q4 2020
67 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q4 2020.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.7M shares
of 127M outstanding shares and own 15.51% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (5.52M shares), Prosight Management, LP (2.02M shares), EMERALD MUTUAL FUND ADVISERS TRUST (1.85M shares), PURA VIDA INVESTMENTS, LLC (1.81M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.49M shares), BlackRock Inc. (1.26M shares), GEODE CAPITAL MANAGEMENT, LLC (715K shares), RENAISSANCE TECHNOLOGIES LLC (646K shares), Laurion Capital Management LP (563K shares), and MORGAN STANLEY (459K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.